Page 2 - Nasdaq Bcda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the...

BioCardia (NASDAQ:BCDA – Get Free Report) and Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings. Profitability This table compares BioCardia and Anavex […]

BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totalling 27,300 shares, a decrease of 84.0% from the July 15th total of 171,000 shares. Based on an average trading volume of 101,600 shares, the […]

Alliance Global Partners lowered shares of BioCardia (NASDAQ:BCDA – Free Report) from a buy rating to a neutral rating in a research report released on Friday morning, FlyOnTheWall reports. Separately, HC Wainwright restated a buy rating and set a $9.00 price objective on shares of BioCardia in a research note on Monday, July 24th. BioCardia […]

Alliance Global Partners cut shares of BioCardia (NASDAQ:BCDA – Free Report) from a buy rating to a neutral rating in a research note issued to investors on Friday, FlyOnTheWall reports. Separately, HC Wainwright reissued a buy rating and issued a $9.00 target price on shares of BioCardia in a research report on Monday, July 24th. […]